Dr. Roach: Man who takes 10 pills a day questions the efficacy of his meds
I am an 84-year-old male in fairly good health for my age. I take 8-10 pills a day, including two over-the-counter ...
MedPage Today on MSN4d
Practice-Changing Win for Aspirin in Colorectal Cancer
SAN FRANCISCO -- In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on ...
Healio3d
Low-dose aspirin reduces colorectal cancer recurrence for patients with PI3K mutations
Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...
Cancer Therapy Advisor6d
Aspirin Linked to Lower Risk of Recurrence in Certain CRC Patients
Adjuvant treatment with aspirin is associated with a lower risk of recurrence at 3 years in CRC patients with PI3K pathway ...
Targeted Oncology5d
Aspirin Halves Recurrence Risk in 3 Years in PIK3CA-Mutated Colorectal Cancer
Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...
Medscape6d
Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls
ACC/AHA/ESC recommends aspirin 81-325 mg daily for patients less than 65 years of age with no other risk factors. However, these guidelines set stricter criteria for high-risk patients with AF and ...
Medscape8d
Cilostazol vs. Aspirin for Recurrent-stroke Prevention
Participants were randomized to receive cilostazol (100 mg twice daily) or aspirin (81 mg once daily) for 1 to 5 years. The primary endpoint was the first occurrence of any stroke. About three ...
FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...
Hosted on MSN17d
Too many people still take low-dose daily aspirin. What you should know.
For decades, taking low-dose aspirin (81 mg) every day was widely recommended as an easy way to prevent heart attacks and strokes. But that changed when growing evidence led the American Heart ...
Biogen Inc.: FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...